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European Radiology Experimental, the new journal launched by the European Society of Radiology, is placed in the
context of three general and seven radiology-specific trends. After describing the impact of population aging,
personalized/precision medicine, and information technology development, the article considers the following
trends: the tension between subspecialties and the unity of the discipline; attention to patient safety; the challenge
of reproducibility for quantitative imaging; standardized and structured reporting; search for higher levels of
evidence in radiology (from diagnostic performance to patient outcome); the increasing relevance of interventional
radiology; and continuous technological evolution. The new journal will publish not only studies on phantoms,
cells, or animal models but also those describing development steps of imaging biomarkers or those exploring
secondary end-points of large clinical trials. Moreover, consideration will be given to studies regarding: computer
modelling and computer aided detection and diagnosis; contrast materials, tracers, and theranostics; advanced
image analysis; optical, molecular, hybrid and fusion imaging; radiomics and radiogenomics; three-dimensional
printing, information technology, image reconstruction and post-processing, big data analysis, teleradiology, clinical
decision support systems; radiobiology; radioprotection; and physics in radiology. The journal aims to establish a
forum for basic science, computer and information technology, radiology, and other medical subspecialties.Introduction
The decision of the European Society of Radiology (ESR)
to launch European Radiology Experimental occurred in
the context of relevant trends influencing the future of
radiology. In changing times, to explore (to experiment)
new ways, methods, and opportunities is important for
spreading awareness of changes and guiding adaption.
This article describes these trends and how experimental
research in radiology (and this new journal) can play a
role. “Today’s research is tomorrow’s practice” [1], and
experimental research is a key factor for entering the
future through the main gate.
Three general trends and seven radiology-specific trends
will be outlined. Both general and specific trends interplay
and many overlap. A graphical representation is given in
Fig. 1, including relevant effects of the various trends. Then,
different meanings of the word experimental and the struc-
ture and role of the new journal will be described.Correspondence: editor@er-x.org
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Population aging
The first general trend is population aging, a major factor
especially in Europe, North America, and China but also,
although at a slower pace, in the rest of the world. In 2002,
the United Nations defined population aging as unprece-
dented, pervasive, enduring, and with profound implications
for many facets of human life [2]. Baby boomers are now
aged. From 2010 to 2040, the population over 65 is ex-
pected to increase from 16.1 to 25.2% in more developed
regions, and from 5.8 to 12.4% in less developed regions in-
cluding China. The population over 80 will increase from
4.3 to 8.6%, and from 0.9 to 2.5%, respectively. In 2050, in
more developed regions, one out of ten inhabitants will be
over 80 [3].
Population aging has two major consequences. On the
one side, physicians should extend their knowledge
about physiology of advanced elderly, changing their par-
adigms about normality. To distinguish between normal
and abnormal will become more challenging. What is
the normal range of cardiac ejection fraction or the nor-
mal glomerular filtration rate of a 90-year-old healthyis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Fig. 1 General and specific trends influencing radiology and radiological research. MDT, multidisciplinary team; IT, information technology; AI,
artificial intelligence
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in the advanced elderly? Indeed, we need studies to gen-
erate new reference ranges, which also consider the in-
creasing ethnic diversity due to migration, especially in
Europe.
On the other side, aging determines epidemiologic
trends. Ischemic and hypertensive heart disease, stroke,
pulmonary infections, cancer, and diabetes still remain
the most relevant causes of death in middle-upper and
high income countries, with dementia being a major
problem for healthcare systems in high income countries
[4]. Image-based innovations in risk stratification,
screening, clinical diagnosis, interventional therapy, and
prognosis in these fields will be welcomed by the jour-
nal. Although risk stratification, screening, and progno-
sis seem to be outside the area of experimental research,
this is not true. Image-based techniques and methods
need tests, refinements, and specifications before they
may be used in practice, as explained below when con-
sidering quantitative radiology. This is also the key for
acquiring a deeper knowledge of the physiology of ad-
vanced elderly.
Personalized and precision medicine
The second general trend includes personalized medicine,
an approach which considers the individual characteristics
of each subject for disease susceptibility, biology, and
prognosis of diseases, and response to treatment. When
the goal is to create a new taxonomy of human diseases
based on molecular biology, we refer to the so-called preci-
sion medicine [5, 6]. This new patient-centred approach
has profound implications for risk stratification andtailored screening or surveillance programs and person-
alized therapies. Molecular biology has a potential part-
nership with molecular imaging. As recently addressed
by the ESR [7], imaging biomarkers can be used in all
these steps, if our community is able to solve the chal-
lenge of standardization and reproducibility [8]. The re-
lation between imaging features and genomics
(radiogenomics) is adding more value to this patient-
centred approach [9]. Biobanks and imaging biobanks
will also play a role [10]. Potential exists for a future in-
tegrated diagnostics framework including both imaging
and pathology, the latter of which has just become
digital, as imaging is since many years.
Personalized and precision medicine does not end with
the individual patient or patient’s disease. In oncology,
tumour heterogeneity should be assumed as a major
factor determining response to therapies [11]. A biopsy-
based approach to multiple tumour lesions has practical
limitations. Thus, radiology is well positioned for map-
ping cancer heterogeneity in the individual patient and
guiding the adaptive therapy, especially if molecular im-
aging, radiomics, radiogenomics and habitat imaging
techniques are used [6, 12, 13].
Patient engagement will improve personalized medi-
cine, especially through the increasing use of mobile
technology and the Internet. Automated emailing and
interactive patient portals are already playing a role, offer-
ing the possibility of electronic access to medical records,
images and reports [14]. Further research is expected on
new software solutions for patient engagement in radi-
ology, from scheduling procedures to follow-up examin-
ation reminders.
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the research on contrast materials and tracers will play
a big role. On the one hand, we should rethink individ-
ual dosages. One possibility is to consider the lean mass
instead of the bodyweight for dose tailoring [15–17].
On the other hand, the development of new contrast
materials and tracers will make the perspective for per-
sonalized and precision medicine more feasible. In this
regard, theranostics, i.e. disease imaging and therapy to-
gether (targeted molecular imaging to follow the drug
delivery pathway), is the most fascinating direction to
follow [18].
Information technology development
Information technology (IT) development is one of the
most important trends impacting individual and social life
worldwide. From current applications on mobile phones
and tablets to applications of artificial intelligence (AI) to
medicine, our future will be strongly influenced by IT.
Radiology was the leading discipline in the medical digital
era [6]. Thus, relevant IT and AI innovations are expected
in radiology and we should try to keep a prominent pos-
ition as IT innovators in the arena of medical specialties.
To this aim, the cooperation with IT scientists is
necessary.
Advanced techniques of quantitative imaging, AI
applications to clinical decision support systems, and big
data analysis are only a few examples of radiology-
specific trends coming from IT development.
Seven radiology-specific trends
Subspecialties versus unity of discipline
The tension between subspecialties and the unity of the
discipline is increasing. Radiology subspecialties have a
long history, with neuroradiology being one major para-
digm of full dedication [19]. Interventional radiology in-
clined to claim for becoming “a primary specialty with
uniquely trained clinicians” [20] or “an almost autono-
mous clinical specialty” [21]. To have radiologists subspe-
cialized in specific fields is an obligatory way to answer
clinical needs, to maintain our central role in multidiscip-
linary teams, and last but not least, to guide both experi-
mental and clinical research. The radiologist embedded in
a clinical team seems to be the best model of radiology
consultation, with a non-negligible trade-off paid to
productivity [22]. Are we risking a fragmentation of
radiology?
To retain the unity of the discipline is not an old con-
servative academic viewpoint but a current need, as
shown by the following considerations: 1. General previous
training can be an advantage in comparison to clinicians
who practice imaging in their field (“neuroradiologists
may offer a differential diagnosis that includes non-
neurologic conditions based on their more generaltraining” [19]); 2. Modern imaging techniques commonly
explore the body of the patient also outside the area of
interest (in the case of cardiac computed tomography, the
detection of a lung tumour can be more important than
coronary stenosis quantification [23]); moreover, in multi-
disciplinary cancer teams, radiologists are frequently asked
for their opinion about diagnosis and interventional treat-
ments of metastases all over the body; 3. The distinction
among subspecialties is blurred, important fields are
cross-bordered, and the identity of subspecialties is always
changing and evolving while imaging techniques migrate
from one subspecialty to another; 4. Organizational as-
pects favour a central radiology department due to the im-
possibility to have radiologists dedicated exclusively to one
subspecialty; additionally, a central radiology department
able to manage large and expensive equipment allows a
more cost-effective work-flow; 5. Some hybrid systems re-
quire the combination of radiology and nuclear medicine
expertise, suggesting a unified training program as has
already been initiated under the unique “Radiology” de-
nomination in 2014 in The Netherlands [24].
Patient safety
A patient-centred approach also includes patient safety,
in particular radioprotection, as highlighted by the
European Society of Radiology (ESR) [25]. Radiologists
should acknowledge the efforts made by the industry
for a reduction of x-ray exposure, especially for com-
puted tomography (CT). The possibility of performing
coronary CT studies with much less than 1 mSv has
been demonstrated [26, 27], while thoracic CT can be
performed with less than 1 mSv (unenhanced studies)
and less than 2 mSv (contrast-enhanced studies) [28].
These dramatic improvements imply two conse-
quences. First, as suggested by the ESR [29], renewal of
radiological equipment will be one of the most import-
ant factor driving the ionizing radiation exposure reduc-
tion in the next years. Second, reporting of radiation
dose, if not already required by local regulations, will be-
come a routine practice as indicated by the European
Union Council Directive 2013/59 [30]. More preclinical
(especially on phantoms) and clinical research is still ex-
pected on radioprotection. Research about the use of
new hardware and software is welcomed by our journal.
A similar reasoning applies for studies aimed at reducing
the dose of both iodinated and gadolinium-based con-
trast materials, the latter especially after the so-called
“brain deposition” issue [31].
Quantitative imaging
Imaging procedures will provide more and more output,
not only images but also clinical data, numbers, indices,
the core of the so-called quantitative imaging. Digital
images are intrinsically data [32]. In certain cases, data
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mineral densitometry and trabecular bone score through
dual energy x-ray absorptiometry, where reproducibility
defines the smallest detectable difference and the time
to follow-up [33–37]. This is crucial for imaging bio-
markers to be used for radiomics and radiogenomics, in
particular for MRI-derived parameters. Radiologists are
generally not ready for this, being mainly trained for
qualitative reporting. For a long time, quantitation has
been limited to the use of electronic calipers for size or
to region-of-interest-based measurements of tissue elec-
tronic density through Hounsfield units in CT.
We should not forget the counterintuitive evolution of
imaging methods for evaluating the response to therapy of
solid tumours, from the two-dimensional criteria (the
cross-product) proposed by the World Health Organization
in 1981 [38] to the one-dimension Response Evaluation
Criteria in Solid Tumours (RECIST) 1.0 in 2000 [39], as
well as the RECIST 1.1 simplification, including positron
emission tomography only in 2009 [40]. Notably, the main
requirement for any new parameter to be accepted by the
non-radiological clinical world is reproducibility. This
explains why a diameter is more reproducible than a
cross-product and the slow adoption of volume measure-
ment [41].
Without reaching reliable standardization and repro-
ducibility, new imaging-derived parameters are deemed
to remain research topics only. A lot of experimental
work is needed on the path to an imaging biomarker de-
velopment and acceptance, proving the concept, the
mechanism, the principle, the efficacy and effectiveness up
to its use as surrogate end-point in clinical studies [42].
Standardized and structured reporting
Radiologic reporting is evolving towards standardized
descriptors and diagnostic categories, in the context of
structured reports. The Breast Imaging Reporting and
Data Systems (BI-RADS), more than two decades after its
first introduction in 1993 [43, 44], has been imitated in
many other fields of diagnostic imaging [45–49] and the
practice of radiology will follow this trend to facilitate the
information transfer to patients and clinicians, including
other radiologists.
Search for a higher level of evidence
We will be increasingly asked to demonstrate that radi-
ology works in favour of patients, not only in terms of
diagnostic performance but also at higher levels of the
evidence-based medicine hierarchy, which implies im-
pact on treatment, patient outcome, and societal effects
[50]. This is now practically evident in the paradigm
shift from a fee-for-service to a value-based model for re-
imbursement [51], in the context of a reduction or at
least an end of expansion of healthcare expenditure [52].Even though this trend mainly implies large clinical
studies, innovation in study design to show efficacy and
effectiveness of radiological procedures can be proposed
through our journal.
Increasing relevance of interventional radiology
A major trend is surely the increasing penetrance of inter-
ventional radiology, which is a fundamental asset to im-
prove the clinical profile of radiology [20, 21]. The role of
minimally invasive image-guided therapies will expand in
the next years, especially concerning interventional oncol-
ogy. For the next generations it is of crucial importance
that we continue to lead the way in device and method
innovation in interventional radiology.
However, we should also try to build higher levels of
evidence in favour of interventional radiology compared
with standard methods, competing with other specialists
working in the field [21]. Notably, the innovation of de-
vices and methods is an easier task than building high-
level evidence, as “most interventional radiologists lack
expertise in the relatively challenging advanced methods
used in comparative effectiveness and cost-effectiveness
research” [20]. This challenge implies efforts in educa-
tion and mentoring, beginning with training during
post-graduation schools.
Technological evolution
Last but not least, we have to consider the continuous
technological evolution of existing imaging methods, the
introduction of new imaging methods as well as various
effects of IT and AI development in the field of medical
imaging.
The general economic context will probably favour
the evolution of existing imaging methods more than
the introduction of new imaging methods. Imaging pro-
cedures will become faster and faster, as has already
happened with CT and MRI, while new hybrid tech-
nologies will be proposed. An intriguing evolution of
existing methods could be an unprecedented portability
of imaging devices [6], especially in the emergency
setting [53]. While phase-contrast x-ray may bring rele-
vant innovations to radiodiagnostics [54–56], optical
and photo-acoustic imaging may come to clinical prac-
tice [57, 58].
We should also take into consideration a sceptical
view, such as that proposed by Eugen Lin in 2011, when
he wrote [52]: “In many cases, our technology has
reached a point where the marginal value of further ad-
vances for patient care may be minimal. […] I believe
that there will be substantially fewer technologic ad-
vances implemented in routine clinical practice in the
near future. But what of the much-touted molecular im-
aging? Although I do not doubt the potential of molecu-
lar imaging compared with existing anatomic imaging
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the same substantial hurdles to reimbursement”. In any
case, the initial evidence provided for new modalities or
techniques in the experimental setting will be necessary
for translation into clinical practice. European Radiology
Experimental will provide a forum for this.
Among the technological evolution we can include IT
development. Radiology information systems will be inte-
grated in hospital and regional/national health informa-
tion systems. All areas of innovation in this field and
their interplays require research by radiologists and IT
experts, as outlined by Nance et al. [59]: aggregation of
electronic medical records, allowing radiologists to ac-
cess clinical information (not only information provided
by ordering clinicians) at hand when defining the proto-
col of a procedure or interpreting images, immediate use
of clinical decision support systems for ordering, inter-
preting, and defining further patient management,
internal peer review, tracking of resident training, com-
munication of critical findings, quality control of tech-
nologists’ performances and communication between
radiologists and technologists, customer service towards
patients and referring physicians, surveillance and out-
come measures, and data mining regarding previous is-
sues (including radiation dose).
It is easy to predict that AI will be increasingly imple-
mented in medical imaging systems. Examples of this
trend are computer aided detection and diagnosis, ad-
vanced image analysis, such as texture energy and deep
learning methods [6], fusion imaging, three-dimensional
printing, structured reporting and new models of relations
of radiologists with patients and referring physicians,
teleradiology.
In particular, clinical decision support systems will be
used by radiologists (management of additional findings,
ordering additional imaging or biopsy, image interpret-
ation) and other clinicians (importantly, when ordering
imaging studies). As a general effect, these systems
should result in an increase in the meaningful and ap-
propriate use of radiology [60]. The available knowledge
on medicine and medical imaging is superior to any hu-
man ability to memorize and correctly exploit it in
favour of patients. Even considering imaging-related arti-
cles only, hundreds of new reports appear online daily.
When searching PubMed for papers including “imaging”
or “radiology”, the number of items obtained per year is
42,757 in 2000, 60,956 in 2005, 94,623 in 2010, 130,353
in 2015; from 2000 to 2015 the number of items per day
went up from 117 to 357, more than a three-fold in-
crease [61]. Only the smart use of information technol-
ogy can allow us for taking advantage of this amount of
available information.
Nowadays, when typical randomized controlled trials
or large prospective comparative studies imply highcosts, proper analysis of the big data we already have in our
radiology information systems [62] can allow for trans-
forming stored information into new knowledge. In the
hierarchy of understanding, an increasing organizational
level grows from data (discrete elements) to information
(linked elements), to knowledge (organized information),
and to wisdom (applied knowledge) [63]. Studies on radio-
logical data in this direction are welcome.
Experimental research in radiology and the structure of the
journal
Radiologists will have to contribute to and guide future
research projects regarding the above described trends.
It is not only a matter of innovation in devices and prod-
ucts, but also a matter of innovation of processes and
methods. Testing devices, products and methods in an
experimental setting is always the first step.
Notably, the word experimental has a wide spectrum
of meanings, providing many opportunities for this jour-
nal. Most commonly regarded as experimental are im-
aging studies on phantoms, cells, or animal models.
However, we also consider studies in which the observer
properly modifies a given practice for a defined outcome
to be measured (a planned variation under controlled
conditions [64]) as “experimental”. Of course, this ap-
plies also to studies on humans and especially on
explorative studies, such as those reporting secondary
end-points of large clinical trials, studies which will also
be considered for publication by the journal.
This profile implies a special characteristic of European
Radiology Experimental: we need a strict cooperation
between clinical imaging specialists (radiologists and
nuclear physicians) and a large variety of other profes-
sionals involved in medical imaging development and
application: biologists, chemists, bioengineers and bio-
mathematicians, experts in computer science, informa-
tion technology and bioinformatics, as well as other
physicians working in medical imaging such as patholo-
gists, geneticists, neurologists, surgeons, cardiologists,
and many more. The journal will establish a public
forum for this large community.
The journal sections are not defined according to the
usual organ/system-based or technique-based subspe-
cialties. Open to future changes, we identified eleven
fields for submission:
1. Biomathematics and computer modelling
2. Contrast materials, tracers, and theranostics
3. Experimental models of human disease
4. Information technology, big data, image
reconstruction and post-processing
5. Imaging biomarkers, radiomics, radiogenomics, and
imaging biobanks
6. Interventional
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8. Methodology and statistics
9. Molecular and hybrid imaging
10.Novel imaging modalities/techniques
11.Radiobiology, radioprotection, and physics in
radiology
As per the aims and scope of the journal, about 50%
of the Editorial Board members are neither radiologists
nor nuclear physicians, thus including expertise from
many other fields. I thank all board members for taking
part in this initiative.
Conclusions
Considering the above described trends, European Radi-
ology Experimental joins the ESR journal family as an
online only and fully (gold) open access journal. This
follows the guidelines defined by the European Union:
papers deriving from projects supported by public funds
should be freely available for reading by 2020 [65]. The
discussion about free access to data supporting the re-
sults of scientific research (the so-called data sharing
[66]) is ongoing and this accessibility should be com-
bined also with ethical, economic, and authorship is-
sues. European Radiology Experimental encourages data
sharing and will work in favour of this.
“The future cannot be predicted, but futures can be
invented”, said Dennis Gabor, the Hungarian Engineer
who received the 1971 Nobel Prize in Physics for the
invention of holography [67]. Of course, this cannot be
achieved through journals alone, but the ESR is already
driving relevant processes, working for the next gener-
ation of radiologists. In these changing times, European
Radiology Experimental can play a pivotal role.
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